Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Alx Oncology Holdings Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +8 vs. Q1 2024
- Shares held
- 48.6M
- +2.90M (+6.3%) vs. Q1 2024
- Total value
- $293.4M
- −$216.6M (−42.5%) vs. Q1 2024
- New holders
- 31
- 38 more added
- Sold out
- 23
- 26 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALXO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 93 | $217.9M |
| Q1 2026 | 69 | $189.0M |
| Q4 2025 | 57 | $33.0M |
| Q3 2025 | 61 | $50.8M |
| Q2 2025 | 61 | $12.1M |
| Q1 2025 | 85 | $21.7M |
| Q4 2024 | 87 | $68.5M |
| Q3 2024 | 92 | $82.7M |
| Q2 2024 | 112 | $293.4M |
| Q1 2024 | 106 | $510.5M |
| Q4 2023 | 93 | $681.5M |
| Q3 2023 | 76 | $159.8M |
| Q2 2023 | 75 | $257.5M |
| Q1 2023 | 86 | $161.4M |
| Q4 2022 | 87 | $410.6M |
| Q3 2022 | 99 | $348.7M |
| Q2 2022 | 97 | $290.7M |
| Q1 2022 | 96 | $621.9M |
| Q4 2021 | 108 | $780.0M |
| Q3 2021 | 115 | $2.55B |
| Q2 2021 | 105 | $1.82B |
| Q1 2021 | 94 | $2.47B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Alx Oncology Holdings Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 705,547 | $4.25M | 0.00% | +151,680+27.4% | Added |
| Millennium Management LLC | 1,325,196 | $7.99M | 0.01% | +1,265,006+2,101.7% | Added |
| Paradigm Biocapital Advisors LP | 1,575,605 | $9.50M | 0.36% | +1,575,605 | New |
| Vanguard Group Inc | 1,727,248 | $10.4M | 0.00% | +160,784+10.3% | Added |
| OrbiMed Advisors LLC | 1,894,462 | $11.4M | 0.24% | −823,508−30.3% | Reduced |
| MPM Oncology Impact Management LP | 2,180,864 | $13.2M | 2.04% | +912,393+71.9% | Added |
| BlackRock Inc. | 2,687,619 | $16.2M | 0.00% | +466,058+21.0% | Added |
| Vestal Point Capital, LP | 3,600,000 | $21.7M | 1.62% | +990,000+37.9% | Added |
| Redmile Group, LLC | 4,036,451 | $24.3M | 1.47% | −290,058−6.7% | Reduced |
| Vivo Capital, LLC | 4,220,048 | $25.4M | 2.35% | 00.0% | Unchanged |
| FMR LLC | 7,814,996 | $47.1M | 0.00% | +292,184+3.9% | Added |
| venBio Partners LLC | 9,699,925 | $58.5M | 25.26% | 00.0% | Unchanged |
| Red Tortoise LLC | 0 | $0 | 0.00% | −340−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −3,142,079−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −106,356−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −98,960−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −59,186−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −49,000−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −36,195−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −23,366−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −20,990−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Bourgeon Capital Management LLC | 0 | $0 | 0.00% | −19,570−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −11,535−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,911−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,289−100.0% | Sold out |
| Forefront Analytics, LLC | 0 | $0 | 0.00% | −10,261−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −10,047−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,514−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,579−100.0% | Sold out |
| Westend Capital Management, LLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Financial Advisory Group | – | – | – | – | Not filed |
| Credit Suisse AG | – | – | – | – | Not filed |